Search results for: methotrexate

Update on Extrapulmonary Sarcoidosis

Lara C. Pullen, PhD | December 6, 2021

Neurosarcoidosis & sarcoid dermatopathology are discussed.

Good Flow: 2021 Updates in Vasculitis

Jason Liebowitz, MD, FACR | December 6, 2021

During the ACR Convergence 2021 annual Review Course, Peter Merkel, MD, MPH, provided recent updates on vasculitis.

Tofacitinib Yields Rapid & Sustained Improvement in JIA

Reuters Staff | December 3, 2021

NEW YORK (Reuters Health)—Tofacitinib significantly reduces the number of flares in children with polyarticular course juvenile idiopathic arthritis (JIA), according to the first phase-3 clinical trial to assess the efficacy of a Janus kinase (JAK) inhibitor in JIA. JIA is a heterogeneous group of chronic conditions with no known cause that develop before age 16…

Management of Inflammatory Myositis: Options for Refractory Disease & New Therapies Discussed

Mary Beth Nierengarten | December 2, 2021

Options to escalate treatment for refractory inflammatory myositis and new therapies in the pipeline are discussed.

Management of Adults with JIA: Uveitis, MAS & More

Mary Beth Nierengarten | December 2, 2021

Mara L. Becker, MD, MSCE, discusses how important it is to effectively treat juvenile idiopathic arthritis at an early stage to improve long-term outcomes in adulthood.

In the Thick of It: Scleroderma Update 2021

Jason Liebowitz, MD, FACR | December 2, 2021

Laura Hummers, MD, MSc, provided an update on the extra-pulmonary manifestations of scleroderma & the best ways to approach management of these issues.

From Strength to Strength: Idiopathic Inflammatory Myopathy Diagnosis & Management

Jason Liebowitz, MD, FACR | December 2, 2021

During the ACR Convergence 2021 Review Course, Rohit Aggarwal, MD, MS, provided an update on idiopathic inflammatory myopathy.

Joint Venture: 2021 Updates in Rheumatoid Arthritis

Jason Liebowitz, MD, FACR | November 24, 2021

An update on the state of RA management was presented by Dr. Bryant England, a co-author of the 2021 ACR Guideline on the Management of Rheumatoid Arthrits, during the Review Course held during ACR Convergence 2021.

Eye-Opening Experiences: Tips from a Rheumatology-Ophthalmology Clinic

Samantha C. Shapiro, MD | November 23, 2021

At ACR Convergence 2021, two doctors provided an overview of inflammatory eye disease and the overlap with systemic rheumatic illnesses.

Reproductive Health & PsA: New ACR Training Program Enhances Provider Education

Mary Beth Nierengarten | November 23, 2021

The ACR has developed educational materials for healthcare providers to use to discuss reproductive health and contraception with their patients with psoriatic arthritis.